Thank you, Chair,
Again, returning to the work that this committee does, the precedent that is being set here actually is that this committee is looking at original documents that have already been studied by the Auditor General and that the Auditor General has already given her analysis on. That's the precedent of the.... Mr. Desjarlais wanted to know from me as a long-time member if I ever signed a non-disclosure agreement in the context of this committee. No, I didn't because this committee never asked for original documents of this nature.
Why wouldn't we ask for them? Because we have the work of the Auditor General before us, because there are other committees that deal with actual contracts. This committee is a review committee. We review the work that has been done and we review that work through the lens of the Auditor General, who certainly has the resources and we can rightfully ask at different times if the Auditor General indeed has all the resources that they need to do their work. We've had that discussion when we look at the main estimates and when we look at the Auditor General's own annual report about the operations of her office.
But coming back to the Auditor General, this really would have been my preference, that we respect the work that the Auditor General did in this case.
I'd like to read the conclusion taken from the Auditor General's news release dated December 6, 2022:A report from Auditor General Karen Hogan tabled today in the House of Commons found that the Public Health Agency of Canada and Health Canada, supported by Public Services and Procurement Canada, responded to the urgency of the coronavirus pandemic in 2020 and secured COVID‑19 vaccine doses so that everyone in Canada who chose to be vaccinated could be. Vaccines were needed quickly to reduce Canadians’ risk of serious illness, hospitalization, and death from COVID‑19.
I feel I don't need to remind everyone that when the vaccines came in, MPs asked if we had talked to our constituents. This report was made public in the media and it was discussed in the public space. I can say that my constituents are very pleased with the work of our public service.
I went to a clinic in my constituency to get my fifth dose of vaccine, and the clinic was full. Some people were there with their children. It was overwhelming and from what the nurse told me, it's like that every day. Parents were very happy to be able to come in with their children, and there was a playground so the children could have a positive experience with the vaccines. It was really impressive. I know it was different elsewhere and other kinds of messages were conveyed.
In my region and in Quebec, people were happy that the vaccines had been developed, purchased and delivered. They were pleased to see that the vaccines worked well.
Of course, it is our role and the Auditor General's role to review the contracts in order to determine if abuse occurred.
The Auditor General's report states:
9.26 In order to protect the commercial confidential information contained in the advance purchase agreements, we used publicly available information and unclassified information to estimate that at 31 May 2022, the average cost of 1 dose was approximately $30, excluding taxes.
I'm going to stop here, for now. Earlier, it was said that elsewhere the cost of a dose might be $12 or $16, for example.
We might have expected the public to react strongly when they heard that the price of a dose was $30. They might have questioned why the price was set at $30 per dose. They might have suggested that we go to Colombia to get a better price per dose. However, that's not what we heard. I believe Canadians realized that was the price we had to pay to get access to the vaccines; they accepted that fact.
I asked the following question at the February 6 meeting:
If we're in a war and win that war, are we then looking at the number of bullets we used and saying, “Well, maybe we used too many bullets”?
Next time, we're going to have to look at how to prevent a situation like this. Actually, that was the role of the Auditor General's report.
I will now continue reading from the report:
The estimated cost per dose will vary over time based on a number of factors, including, but not limited to, the effects of changes in foreign currency exchange rates and in market forces, such as supply and demand.
Firm contracts or other ways to monitor that come to mind.
I will continue:
As a result, at the end of our audit period, the Government of Canada had spent approximately $5 billion on vaccines for the 169 million doses paid for between December 2020 and May 2022…
Personally, I follow the media every day. That said, I've never heard people say that the government paid way too much for vaccines, which saved the lives of hundreds of thousands of Canadians. If any other members have received complaints about this from the constituents they represent, I would ask them to let us know.
In any Auditor General's report, the recommendations are the most important thing.
Based on the information that the Auditor General was able to give us about the prices, terms and conditions of the contracts, one would have expected her to conclude, if that had been the case, that officials should do a better job negotiating future contracts, or following Colombia's standards, for example, or that they should look into other means.
The Auditor General could have said that the contract should be free of confidentiality provisions, but she didn't. Instead, her recommendations are along the lines of the one found in section 9.57, which reads as follows:9.57 Recommendation. To minimize further wastage, the Public Health Agency of Canada should draw on the lessons learned from its management of the COVID‑19 vaccine supply and work with other implicated federal organizations and stakeholders to adjust its management of COVID‑19 vaccine surpluses.
I agree wholeheartedly. The Public Health Agency also agrees. We asked questions about that.